Vaccines in clinical trials: infectious disease

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Eleanor Barnes does not receive any financial support from industry in the form of salary, honoraria or travel assistance. She is funded by the MRC UK. Andrew J Pollard does not currently receive any financial support from industry in the form of honoraria or travel assistance. He acts as chief investigator for clinical trials on behalf of Oxford University funded/sponsored by vaccine manufacturers and his department has received unrestricted educational grants to fund conferences/courses which Andrew J Pollard has organized. Eleanor Barnes and Andrew J Pollard receive funding from the NIHR Oxford Biomedical Research Centre and the NIHR Thames Valley Comprehensive Local Research Network. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.